BEGIN ARTICLE PREVIEW:
Manhattan-based Additive Manufacturing service, Print Parts Inc., collaborated with PostProcess Technologies to rapidly scale efforts used in the production of 3D printed nasopharyngeal (NP) swabs for New York City’s COVID-19 Test Kits. At the peak of the pandemic, Print Parts began working with NYC to scale up production of NP swabs for the emergency supply of COVID test kits.
Print Parts opened an ISO 13485 compliant production lab in Manhattan and put together a dedicated supply chain to produce over one million Nasopharyngeal (NP) swabs for COVID test kits. In order to rapidly scale production and meet the demand for NYC, Print Parts implemented the PostProcess DEMI Resin Removal solution.
Print Parts expanded its in-house printing capabilities with the purchase of eight medical-grade Envision One cDLM 3D printers from EnvisionTEC. Using a more common rinse method with isopropyl alcohol (IPA) for resin removal, it would have taken over 20 minutes to clean each batch of swabs. The software-controlled DEMI solution allowed Print Parts to process multiple batches of swabs, completely hands-free, in a single 90-second submersion with a quick IPA rinse afterwards. This helped Print Parts reduce the entire resin removal process time by 5x and simplify their post-printing processing.
END ARTICLE PREVIEW